Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 1–25 of 7,816 matching trials · page 1 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
The LUCINDA Trial: LeUprolide Plus Cholinesterase Inhibition to Reduce Neurological Decline in Alzheimer's NCT03649724 Placebo; Eligard 22.5Mg Suspension for Injection Runs in: United States · 3 sites |
PHASE2 symptomatic-cholinergic |
COMPLETED | 86 | Weill Medical College of Cornell University OTHER |
2026-09-21 |
|
The Revitalize Study in Older Adults at Risk for Alzheimer's Disease NCT04018092 Active NIR-PBM; Sham NIR-PBM Runs in: United States · 2 sites |
PHASE2 other |
COMPLETED | 168 | University of Florida OTHER |
2026-09-21 |
|
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease NCT04031469 There is no intervention in this study Runs in: United States · 1 site |
NA other |
SUSPENDED | 1,000 | ProgenaBiome OTHER |
2026-09-21 |
|
A Phase 3 Study to Evaluate Efficacy and Safety of AL001 in Frontotemporal Dementia (INFRONT-3) NCT04374136 Part 1 Blinded - AL001; Part 1 Blinded - Placebo; Part 2 (OLE Treat... Runs in: Argentina; Australia; Belgium; Canada; France; Germany; G... · 44 sites |
PHASE3 other |
TERMINATED | 119 | Alector Inc. INDUSTRY |
2026-09-21 |
|
Comparison of Two Group Wellness Interventions for Individuals With Neurologic Conditions and Their Support Persons NCT05048966 Group Wellness Class 1; Group Wellness Class 2 Runs in: United States · 1 site |
NA other |
RECRUITING | 360 | Kessler Foundation OTHER |
2026-09-21 |
|
SYNERGIC-2 Trial (SYNchronizing, Exercises and Remedies to GaIn Cognition@Home) NCT05375513 PMI@Home; Brain Health Pro Runs in: Canada · 8 sites |
NA other |
RECRUITING | 250 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's OTHER |
2026-09-21 |
|
PET Imaging Tau Accumulation in FTLD and Atypical Alzheimer's Using [18F]-PI-2620 NCT05456503 [18F]-PI-2620 Runs in: United States · 1 site |
PHASE3 other |
RECRUITING | 72 | University of Pennsylvania OTHER |
2026-09-21 |
|
Promoting Goals-of-Care Discussions for Patients With Memory Problems and Their Caregivers NCT05596760 Jumpstart Guide Runs in: United States · 3 sites |
NA other |
ACTIVE_NOT_RECRUITING | 1,802 | University of Washington OTHER |
2026-09-21 |
|
Effect of Acetylcholinesterase Inhibitors on Bone Metabolism NCT06041789 Donepezil; Memantine Runs in: United States · 1 site |
PHASE2 symptomatic-cholinergic |
RECRUITING | 45 | Duke University OTHER |
2026-09-21 |
|
Promoting Physical Activity in Older Hispanic/Latino(a) Adults NCT06362824 De Pie Intervention; Active Comparison Group: Healthy Actions And L... Runs in: United States · 2 sites |
NA other |
ACTIVE_NOT_RECRUITING | 130 | Kaiser Permanente OTHER |
2026-09-21 |
|
Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease NCT06847321 LHP588; LHP588; Placebo Drug Runs in: United States · 39 sites |
PHASE2 other |
RECRUITING | 300 | Lighthouse Pharmaceuticals, Inc. INDUSTRY |
2026-09-21 |
|
Amyloid PET Imaging in the Baltimore Longitudinal Study of Aging NCT07099053 Runs in: United States · 1 site |
NA other |
RECRUITING | 400 | National Institute on Aging (NIA) NIH |
2026-09-21 |
|
PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) NCT07169630 18F-PF974; 18F-florbetaben Runs in: United States · 1 site |
PHASE1 other |
RECRUITING | 90 | National Institute of Mental Health (NIMH) NIH |
2026-09-21 |
|
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies NCT07177352 No Intervention Runs in: Argentina; Australia; Brazil; Canada; Chile; China; Denma... · 229 sites |
PHASE3 other |
RECRUITING | 80,000 | Hoffmann-La Roche INDUSTRY |
2026-09-21 |
|
Improving Neurological Health With Acetylcholine Via Neuroplasticity-based Computerized Exercise in Mild Cognitive Impairment NCT07243600 Computerized speed-based cognitive training; Computerized executive... Runs in: Canada · 1 site |
NA other |
RECRUITING | 84 | Posit Science Corporation INDUSTRY |
2026-09-21 |
|
Study to Evaluate the Pharmacodynamics, Safety and Efficacy of SKY-0515 in Participants With Huntington's Disease NCT07378644 SKY-0515; SKY-0515 Placebo Runs in: Argentina; Brazil; Canada; Chile; Colombia; Georgia; Germ... · 24 sites |
PHASE2|PHASE3 other |
RECRUITING | 400 | Skyhawk Therapeutics, Inc. INDUSTRY |
2026-09-21 |
|
The Gut - PRO Study NCT07413744 Probiotic; Placebo Runs in: United States · 1 site |
PHASE1 other |
RECRUITING | 40 | University of Wisconsin, Madison OTHER |
2026-09-21 |
|
Escalating Doses of Memantine in Down Syndrome (MEDS-123) NCT07531940 Memantine Runs in: United States · 1 site |
PHASE1 symptomatic-cholinergic |
NOT_YET_RECRUITING | 25 | University Hospitals Cleveland Medical Center OTHER |
2026-09-21 |
|
Adapting Behavioral Interventions for Dementia to Address NCDs and Mental Health NCT07543341 BECOME-D Intervention Runs in: Nepal · 1 site |
NA other |
COMPLETED | 12 | Possible OTHER |
2026-09-21 |
|
Music for Pain and Dementia NCT07602283 Drumming session; Music-listening session Runs in: United States · 1 site |
NA other |
RECRUITING | 60 | Yale University OTHER |
2026-09-21 |
|
Comparing Two Acute Care Transition Programs for Older Adults and Their Family Caregivers NCT07661355 Patient-Centered Program; Family Caregiver Enhanced Program Runs in: United States · 4 sites |
NA other |
RECRUITING | 2,560 | Wake Forest University Health Sciences OTHER |
2026-09-21 |
|
A Retrospective Database Study for the Development and Validation of Algorithms for Intracerebral Hemorrhage and Seizures in Alzheimer's Disease NCT07723950 No intervention Runs in: United States · 1 site |
NA other |
ACTIVE_NOT_RECRUITING | 600 | Eisai Inc. INDUSTRY |
2026-09-21 |
|
Study to Test Effects and Safety of RO7568282 in Early Symptomatic Alzheimer's Disease NCT07781657 RO7568282; Placebo |
PHASE2 other |
NOT_YET_RECRUITING | 450 | Hoffmann-La Roche INDUSTRY |
2026-09-21 |
|
Microbiome in Aging of Gut and Brain NCT07799402 Runs in: United States · 1 site |
NA other |
RECRUITING | 700 | University of South Florida OTHER |
2026-09-21 |
|
Virtual Reality Training to Support Daily Activities for People Living With Dementia NCT07829913 At-Home VR-Based IADL Training; Cognitive Stimulation Activities |
NA other |
NOT_YET_RECRUITING | 40 | Indiana University OTHER |
2026-09-21 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial